A case–control study of non-alcoholic fatty liver disease in breast cancer

Abstract Background  Patients with breast cancer sometimes present with increased liver enzymes during follow-up period that may be consistent with hepatic steatosis. This effect known as non-alcoholic fatty liver diseas